Literature DB >> 18090295

Dysfunctional natural killer cells, in vivo, are governed by HIV viremia regardless of whether the infected individual is on antiretroviral therapy.

Edward Barker, Jeff Martinson, Cicely Brooks, Alan Landay, Steven Deeks.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18090295     DOI： 10.1097/QAD.0b013e3282f1d658

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  14 in total

Review 1.  Unravelling the mechanisms of durable control of HIV-1.

Authors:  Bruce D Walker; Xu G Yu
Journal:  Nat Rev Immunol       Date:  2013-07       Impact factor: 53.106

Review 2.  Role of natural killer cells in HIV pathogenesis.

Authors:  Jeffrey Ward; Edward Barker
Journal:  Curr HIV/AIDS Rep       Date:  2008-02       Impact factor: 5.071

3.  HIV-1 Control by NK Cells via Reduced Interaction between KIR2DL2 and HLA-C∗12:02/C∗14:03.

Authors:  Zhansong Lin; Kimiko Kuroki; Nozomi Kuse; Xiaoming Sun; Tomohiro Akahoshi; Ying Qi; Takayuki Chikata; Takuya Naruto; Madoka Koyanagi; Hayato Murakoshi; Hiroyuki Gatanaga; Shinichi Oka; Mary Carrington; Katsumi Maenaka; Masafumi Takiguchi
Journal:  Cell Rep       Date:  2016-11-22       Impact factor: 9.423

4.  Receptor-ligand requirements for increased NK cell polyfunctional potential in slow progressors infected with HIV-1 coexpressing KIR3DL1*h/*y and HLA-B*57.

Authors:  Philomena Kamya; Salix Boulet; Christos M Tsoukas; Jean-Pierre Routy; Réjean Thomas; Pierre Côté; Mohamed-Rachid Boulassel; Jean-Guy Baril; Colin Kovacs; Stephen A Migueles; Mark Connors; Todd J Suscovich; Christian Brander; Cecile L Tremblay; Nicole Bernard
Journal:  J Virol       Date:  2011-04-06       Impact factor: 5.103

5.  The natural killer cell interferon-gamma response to bacteria is diminished in untreated HIV-1 infection and defects persist despite viral suppression.

Authors:  Stephanie M Dillon; Eric J Lee; Julia M Bramante; Edward Barker; Cara C Wilson
Journal:  J Acquir Immune Defic Syndr       Date:  2014-03-01       Impact factor: 3.731

6.  Role of natural killer cells in a cohort of elite suppressors: low frequency of the protective KIR3DS1 allele and limited inhibition of human immunodeficiency virus type 1 replication in vitro.

Authors:  Karen A O'Connell; Yefei Han; Thomas M Williams; Robert F Siliciano; Joel N Blankson
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

Review 7.  Effector mechanisms in HIV-1 infected elite controllers: highly active immune responses?

Authors:  Joel N Blankson
Journal:  Antiviral Res       Date:  2009-09-04       Impact factor: 5.970

8.  The impact of HIV-1 infection and exposure on natural killer (NK) cell phenotype in Kenyan infants during the first year of life.

Authors:  Jennifer A Slyker; Barbara Lohman-Payne; Grace C John-Stewart; Tao Dong; Dorothy Mbori-Ngacha; Kenneth Tapia; Ann Atzberger; Stephen Taylor; Sarah L Rowland-Jones; Catherine A Blish
Journal:  Front Immunol       Date:  2012-12-31       Impact factor: 7.561

9.  CD56negCD16⁺ NK cells are activated mature NK cells with impaired effector function during HIV-1 infection.

Authors:  Jeffrey M Milush; Sandra López-Vergès; Vanessa A York; Steven G Deeks; Jeffrey N Martin; Frederick M Hecht; Lewis L Lanier; Douglas F Nixon
Journal:  Retrovirology       Date:  2013-12-18       Impact factor: 4.602

10.  Baseline natural killer and T cell populations correlation with virologic outcome after regimen simplification to atazanavir/ritonavir alone (ACTG 5201).

Authors:  John E McKinnon; Robbie B Mailliard; Susan Swindells; Timothy J Wilkin; Luann Borowski; Jillian M Roper; Barbara Bastow; Mary Kearney; Ann Wiegand; John W Mellors; Charles R Rinaldo
Journal:  PLoS One       Date:  2014-05-06       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.